Eosinophilic Pneumonia Induced by Medications: An Analysis of Real-World Data from FAERS and Vigibase Identifying Safety Signals and Risk Trends - Scorecard - MDSpire
Advertisement
Eosinophilic Pneumonia Induced by Medications: An Analysis of Real-World Data from FAERS and Vigibase Identifying Safety Signals and Risk Trends
Clinical Scorecard: Eosinophilic Pneumonia Induced by Medications: An Analysis of Real-World Data from FAERS and Vigibase Identifying Safety Signals and Risk Trends
At a Glance
Category
Detail
Condition
Eosinophilic Pneumonia (EP)
Key Mechanisms
Oxidative stress mediated by eosinophil peroxidase and major basic protein; granule proteins inducing tissue damage and fibrosis.
Target Population
Individuals aged 45 to 64 years, particularly those with polypharmacy.
Care Setting
Hospitalized patients and outpatient settings.
Key Highlights
15,374 cases of drug-induced EP identified in FAERS.
Daptomycin, nivolumab, and pembrolizumab are the most frequently reported drugs.
35.4% of affected patients required hospitalization.
Early discontinuation of the offending drug and corticosteroid therapy are crucial for management.
Age, body weight, and polypharmacy are associated risk factors.
Guideline-Based Recommendations
Diagnosis
Utilize SMQ 20000159 for identifying eosinophilic pneumonia cases.
Management
Discontinue the offending drug and initiate corticosteroid therapy promptly.
Monitoring & Follow-up
Monitor for signs of respiratory distress and eosinophilia in patients on implicated medications.
Risks
Increased risk of eosinophilic pneumonia associated with certain medications, particularly daptomycin.
Patient & Prescribing Data
Patients aged 45 to 64 years, particularly those on multiple medications.
Corticosteroids are effective in managing drug-induced eosinophilic pneumonia.
Clinical Best Practices
Implement multidisciplinary collaboration for optimal management.
Educate patients on the signs and symptoms of eosinophilic pneumonia.
Conduct regular reviews of medications in patients with respiratory symptoms.
